Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation

被引:0
作者
Laimoud, Mohamed [1 ,2 ]
Hakami, Emad [3 ]
Maghirang, Mary Jane [3 ]
Mohamed, Tahir [4 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Crit Care Dept, Riyadh, Saudi Arabia
[2] Cairo Univ, Crit Care Med Dept, Cairo, Egypt
[3] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Nursing Dept, Riyadh, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Med Dept, Riyadh, Saudi Arabia
关键词
Diastolic pulmonary gradient (DPG); Pulmonary vascular resistance (PVR); Transpulmonary gradient (TPG); Heart transplantation; Left ventricular assist device (LVAD); HeartMate III; Right ventricular failure (RVF); Mortality; WEDGE PRESSURE-GRADIENT; HYPERTENSION; CANDIDATES; GUIDELINES; RESISTANCE; DIAGNOSIS; SOCIETY; DISEASE;
D O I
10.1186/s43044-023-00428-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The left ventricular assist devices (LVADs) are increasingly used for advanced heart failure as a bridge to heart transplantation or as a destination therapy. The aim of this study was to investigate the changes of diastolic pulmonary gradient (DPG), pulmonary vascular resistance (PVR) and transpulmonary gradient (TPG) after LVAD implantation and their impact on survival after LVAD and heart transplantation.Results A total of 73 patients who underwent LVAD (HeartMate III) implantation between 2016 and 2022 were retrospectively studied. According to pre-LVAD catheterization, 49 (67.1%) patients had DPG < 7 mmHg and 24 (32.9%) patients had DPG >= 7 mmHg. The patients with a pre-VAD DPG >= 7 mmHg had higher frequencies of right ventricular (RV) failure (p < 0.001), RVAD insertion (p < 0.001), need for renal replacement therapy (p = 0.002), total mortality (p = 0.036) and on-VAD mortality (p = 0.04) with a longer ICU stay (p = 0.001) compared to the patients with DPG < 7 mmHg. During the follow-up period of 38 (12-60) months, 24 (32.9%) patients died. Pre-LVAD DPG >= 7 mmHg (adjusted HR 1.83, 95% CI 1.21-6.341, p = 0.039) and post-LVAD DPG >= 7 mmHg (adjusted HR 3.824, 95% CI 1.482-14.648, p = 0.002) were associated with increased risks of mortality. Neither pre-LVAD TPG >= 12 (p = 0.505) nor post-LVAD TPG >= 12 mmHg (p = 0.122) was associated with an increased risk of death. Pre-LVAD PVR >= 3 WU had a statistically insignificant risk of mortality (HR 2.35, 95% CI 0.803-6.848, p = 0.119) while post-LVAD PVR >= 3 WU had an increased risk of death (adjusted HR 2.37, 95% CI 1.241-7.254, p = 0.038). For post-transplantation mortality, post-LVAD DPG >= 7 mmHg (p = 0.55), post-LVAD TPG >= 12 mmHg (p = 0.85) and PVR >= 3 WU (p = 0.54) did not have statistically increased risks. The logistic multivariable regression showed that post-LVAD PVR >= 3 WU (p = 0.013), post-LVAD DPG >= 7 mmHg (p = 0.026) and RVF (p = 0.018) were the predictors of mortality after LVAD implantation. Pre-LVAD DPG >= 7 mmHg (p < 0.001) and pre-LVAD PVR >= 3 WU (p = 0.036) were the predictors of RVF after LVAD implantation.Conclusions Persistently high DPG was associated with right ventricular failure and mortality after LVAD implantation rather than after heart transplantation. DPG is a better predictor of pulmonary vascular remodeling compared to TPG and PVR. Further larger prospective studies are required in this field due to the growing numbers of patients with advanced heart failure, as possible candidates for LVAD implantation, and limitations of heart transplantation.
引用
收藏
页数:13
相关论文
共 34 条
  • [1] Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients
    Alba, Ana Carolina
    Rao, Vivek
    Ross, Heather J.
    Jensen, Annette S.
    Sander, Kaare
    Gustafsson, Finn
    Delgado, Diego H.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (11) : 1253 - 1258
  • [2] Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation
    Alnsasra, Hilmi
    Asleh, Rabea
    Schettle, Sarah D.
    Pereira, Naveen L.
    Frantz, Robert P.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Maltais, Simon
    Daly, Richard C.
    Stulak, John M.
    Rosenbaum, Andrew N.
    Behfar, Atta
    Kushwaha, Sudhir S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (16):
  • [3] Regression of "fixed" pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices
    Beyersdorf, Friedhelm
    Schlensak, Christian
    Berchtold-Herz, Michael
    Trummer, Georg
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (04) : 747 - 749
  • [4] Right heart failure after left ventricular assist device: From mechanisms to treatments
    Bravo, Claudio A.
    Navarro, Andrew G.
    Dhaliwal, Karanpreet K.
    Khorsandi, Maziar
    Keenan, Jeffrey E.
    Mudigonda, Parvathi
    O'Brien, Kevin D.
    Mahr, Claudius
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients
    Cowger, Jennifer A.
    Naka, Yoshifumi
    Aaronson, Keith D.
    Horstmanshof, Douglas
    Gulati, Sanjeev
    Rinde-Hoffman, Debbie
    Pinney, Sean
    Adatya, Sirtaz
    Farrar, David J.
    Jorde, Ulrich P.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (01) : 15 - 24
  • [6] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (01) : 67 - +
  • [7] Diastolic Pulmonary Vascular Pressure Gradient A Predictor of Prognosis in "Out-of-Proportion" Pulmonary Hypertension
    Gerges, Christian
    Gerges, Mario
    Lang, Marie B.
    Zhang, Yuhui
    Jakowitsch, Johannes
    Probst, Peter
    Maurer, Gerald
    Lang, Irene M.
    [J]. CHEST, 2013, 143 (03) : 758 - 766
  • [8] Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular Resistance
    Grupper, Avishay
    Mazin, Israel
    Faierstein, Kobi
    Kurnick, Adam
    Maor, Elad
    Elian, Dan
    Barbash, Israel M.
    Guetta, Victor
    Regev, Ehud
    Morgan, Avi
    Segev, Amit
    Lavee, Jacob
    Fefer, Paul
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [9] 2023 National Heart Center/Saudi Heart Association Focused Update of the 2019 Saudi Heart Association Guidelines for the Management of Heart Failure
    Habeeb, Waleed Al
    Tash, Adel
    Elasfar, Abdelfatah
    Almasood, Ali
    Bakhsh, Abeer
    Elshaer, Fayez
    Ayoubi, Fakhr Al
    AIghalayini, Kamal Waheeb
    AlQaseer, Maryam Mohammed
    Alhussein, Mosaad
    Almogbel, Osama
    AlSaif, Shukri Merza
    AlHebeshi, Yahia
    [J]. JOURNAL OF THE SAUDI HEART ASSOCIATION, 2023, 35 (01) : 71 - 134
  • [10] Humbert M, 2022, report